chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a physician via company representatives, referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 11-SEP-2015, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB (Lot No. J007946; expiration date 24-MAR-2016), " TF 5mcg/0.5mL Te" (route of administration and anatomical location were not reported). On an unspecified dates, the RECOMBIVAX HB had four temperature excursions: 48 hours (Lowest recorded temperature was 0 F (0 Celsius); 24 hours (Lowest recorded temperature was -1 F (-1 Celsius); 48 hours (Lowest recorded temperature was 1 F (1 Celsius) and 72 hours (Highest recorded temperature was 9 F (9 Celsius). No adverse effects reported. The vaccine status was reported as "in excursion". The vaccine storage criteria and the storage type of excursion were reported as "Refrigerator(R)". No product quality complaint was involved.
feeling a lot of pain on her legs like a lot of discomfort; pain in her legs; Doxycycline and the vaccine has interaction; Couldn't sleep due to the pain; bitter taste in her mouth; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 48 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 30Jul2021 (Lot number: GW0189) at the age of 48 years as dose 1, single for covid-19 immunization. Relevant medical history included: "Lyme's disease" (unspecified if ongoing), notes: Diagnosed 1.5 years ago; "Headache" (unspecified if ongoing). Concomitant medication(s) included: NAPROXEN taken for headache.  The following information was reported: POTENTIATING DRUG INTERACTION (non-serious) with onset 03Aug2021, outcome "unknown", described as "Doxycycline and the vaccine has interaction"; DYSGEUSIA (non-serious) with onset 30Jul2021, outcome "recovered" (30Jul2021), described as "bitter taste in her mouth"; LIMB DISCOMFORT (non-serious) with onset 04Aug2021, outcome "recovering", described as "feeling a lot of pain on her legs like a lot of discomfort"; INSOMNIA (non-serious) with onset Aug2021, outcome "unknown", described as "Couldn't sleep due to the pain"; PAIN IN EXTREMITY (non-serious) with onset 04Aug2021, outcome "recovering", described as "pain in her legs". Therapeutic measures were taken as a result of limb discomfort, insomnia, pain in extremity.  Additional Information: The caller is calling about the Pfizer covid 19 vaccine. On Friday the caller got the covid 19 vaccine. That day the caller didn't have and side effects other than a bitter taste in her mouth, similar to medicine. The caller had a medical appointment because she has Lyme disease. They sent the caller an antibiotic, doxycycline 100 mg. The caller started the antibiotic on Tuesday night. The caller is feeling a lot of pain on her legs like a lot of discomfort. The caller has already started taking the antibiotic.  No follow-up attempts are possible. No further information is expected.
Pt experienced SOB the day after he received his covid 19 vaccine.  He continues to have SOB.
It started at 2am of 03/24/21, client had bad headache and bad body aches describes as "got hit by a truck" and was crying and no sleep until 7am that morning. About 10/10 in pain scale when asked. Took Aleve around 10pm that night, but it did not help. Took Robitussin at 7am and it helped out to get some sleep. Around noon, client reports from 10/10 went down to 2/10, still having sore arm, but reports feeling better compared at 2am. Advised to call us back at the clinic if any other concern(s) that may arise or to call PCP.  Client verbalizes understanding and no other concerns.  Additional info: Client had history of having rash and itchiness on site of injection, cheek, and leg from the 1st dose of Moderna dated 02/23/21 and VAERS report was made when came back for her 2nd dose on 03/23/21.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. Patient's concurrent conditions, medical history and concomitant medications were not provided. On 26-MAY-2017, the patient was inadvertently vaccinated with an expired dose of GARDASIL lot # L035105 expiration date on 14-MAY-2017 for prophylaxis. No adverse effects reported. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1706USA010259: Original Case: 1706USA010259.
Itchy; Trouble staying asleep; I'm breastfeeding; I'm breastfeeding; This is a spontaneous report received from a contactable consumer (Patient). A 34-year-old female patient received BNT162B2 (PIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: FA7485), Solution for injection, via an unspecified route of administration, administered in Arm Left on 11Aug2021 (at the age of A 34-year-old) as unknown, single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 Prior to vaccination. The patient had not been tested for COVID-19 Since the vaccination. On 11ug2021, the patient experienced itchy, trouble staying asleep and she was breastfeeding. The seriousness was reported as non-serious by the reporter. No treatment was received to treat adverse events. The event itchy, trouble staying asleep was recovered on an unspecified date in Aug2021 and outcome of other events were unknown.  Follow-up attempts are completed. No further information is expected.
The night I received the vaccine, I was ordered to wait, then when I got home, I had a red welp on my arm. The welp stayed pass a few days, then today it has tripled in size and is very hard and heated. It is still tender to the touch and is very very hot.
flu; Initial information was received on 03-Oct-2021 regarding an unsolicited valid non-serious case received from a consumer/non-health care professional (patient) via social media.  This case involves an unknown demographics patient who experienced flu (influenza) after receiving vaccine INFLUENZA VACCINE.  It is unknown if the patient experienced any additional symptoms/events. Medication Details and reason for taking the medicine.  It is unknown if the patient had any medical history, concomitant disease or risk factor.  Medical treatment, concomitant medication, vaccination and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiry date: not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  There were no lab data/results available.  It was reported "I've had the flu jab because of my work for the past 20 years. In July this year I got the flu."  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome of the event was unknown.  There will be no information available on the batch number for this case.
Patient received Covid Moderna vaccine on 4/30/22 the went to the Emergency Department on 5/4/22 due to left leg pain.  US Left Duplex Extremity Vein  indicated occluding thrombus left greater saphenous vein.  Patient prescribed Rivaroxaban/Xarelto 10 mg tabs, 1 tab daily for at least 3 months with a follow up  US Left Duplex Extremity Vein ordered to be completed on or after 5/20/22
Developed diffuse hives and itchiness few hours post immunizations that lasted for two days in addition to rash consistent with systemic mastocytosis
Patient presented on 10/04/2017 with redness and swelling on upper left arm, area below shoulder above elbow.
I started feeling in my right knee - back side - it turned into a very painful, growing pains type of ache. I had an ultrasound, but they said I had no blood clots. It was paining all the way down to my foot. He put me on Meloxicam. That didn't help at all - I've been on it for four or five days. I took Aleve and that didn't touch it. I can barely walk 200 ft., it's that painful. I called my doctor today to see about a referral to an Orthopedic. I didn't do anything, that I can recall, to injure my leg like this. It's internal.  I had the flu vaccine - It was a month before the COVID-19 vaccine dose 3. I had the high dose. It was in my left shoulder.
pt was in car w/mom 15-20 min p/vax had sz assoc w/cyanosis; pt was brought back to clinic still c/o difficulty breathing & appeared to have circumoral cyanosis;
Within ~15 mins of receiving first vaccine - patient started complaining of difficulty breathing , sob, and had a vasovagal response, patient given EPI Pen in the vaccine clinic, then taken on gurney to the ED
Patient was very ill and homebound.  Her son has to physically carry her to move her from one place to another and she is considered homebound.
Swelling, redness, warmth at injection site on left upper arm extending out approx. 4 in. in diameter.
slight headache, it turned into migraine; arm was sore; fever was 100.3; extremely exhausted; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (slight headache, it turned into migraine), PERIPHERAL SWELLING (arm was sore), PYREXIA (fever was 100.3) and FATIGUE (extremely exhausted) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypothyroidism. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, the patient experienced MIGRAINE (slight headache, it turned into migraine), PERIPHERAL SWELLING (arm was sore), PYREXIA (fever was 100.3) and FATIGUE (extremely exhausted). On 25-Feb-2021, MIGRAINE (slight headache, it turned into migraine) had resolved. On 26-Feb-2021, PERIPHERAL SWELLING (arm was sore), PYREXIA (fever was 100.3) and FATIGUE (extremely exhausted) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Feb-2021, Pyrexia: (High) 100.3.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication details was reported.
I had the vaccine on 3/3/21. I went to bed that night as normal. I woke up at 6 am with the worst headache I have ever had in my life. I got up to get headache meds and to use the restroom and I went back to bed. Then I realized this is the first time in 10 years I haven?t woke up coughing. It?s been 14 days and I?m still not coughing. I have been on oxygen for around 6 months and I no longer need it. The first appt I could get with the lung dr is on 3/22. I am going to get  breathing test to see if my lung function has improved. I am truly thankful for this vaccine because it is healing my lungs.
I had a sore throat which I treated with RICOLA throat lozenges. I also had a cough which I took benzonatate. I tested positive for COVID-19 on November 01, 2022. We had a telephone conference call, and the doctor prescribed the benzonatate. The cough got worse, but the sore throat got better but the cough got worse. It took about 4 days. I am still tired, and it seems like my blood sugar is lower since having COVID-19. I am shaky in between meals so I am going to speak with my doctor about this symptom. I still have sinus congestion and a little cough but for the most part I have recovered from him.
I had arm soreness  in the same area as the injection the next morning. I tried to use a little bit of ibuprofen and  acetaminophen and it didn't help at all. And there was muscle stiffness. It got worse the next day, and the next day and the next day. I kept trying to treat it with the ibuprofen and acetaminophen. They told me to use Naproxen. My arm was still sore all the way down. A month later, it slowly started with a dent in my arm - it was going across the arm starting with the site and then to the front of the arm. It really dented in. I called the doctor and to get in to the doctor it took awhile - it may have been in March or late February when I finally got in. I tried to keep treating it with Naproxen and acetaminophen. I couldn't push or pull anything with it. I was in a lot of pain. I work in caregiving - with 20 years with special needs who are self sufficient - I don't do lifting at work. I drive them to appts and help them get meals. It was continuous pain from the time of the vaccination. I couldn't use my arm at all. I finally had physical therapy - shortly after my doctor visit (in March) was the first session. I did physical therapy for 6 weeks and it cost over $900 and I couldn't afford anymore. The pain subsided if I rotated heat and ice and heat and ice. If I feel the site or push on it - it still has pain in it. I had extreme pain still  on February 5th (Pfizer - Lot EL9264) when I received was second dose and I had them put that injection in the left arm and that had no problem whatsoever. At physical therapy - they gave me at home exercises to keep working the arm using the instructions they gave me. I still have the dent in my arm. That hasn't gone away. My right arm is nice and round like a muscle should me - but there is a dent like someone has deflated the muscle. I have a lot less pain and I can use the arm now but there is still pain and there is still the deflated dent area.
Site: Pain at Injection Site-Severe, Systemic: Unable to Sleep-Medium, Additional Details: pt reported "sirva" - left shoulder pain and limited range of motion, painful to touch, difficulty sleeping. pt has not sought medical help. took ibuprofen.
have not received second dose; Swollen lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swollen lymph nodes) and PRODUCT DOSE OMISSION ISSUE (have not received second dose) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced LYMPHADENOPATHY (Swollen lymph nodes). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (have not received second dose). On 06-Mar-2021, LYMPHADENOPATHY (Swollen lymph nodes) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (have not received second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 13-Aug-2021: Non-significant follow up, patient demographic was updated.
First phase: 6 weeks of intense flu-like illness including rash on hands, 3 possible blot clot events (2 left leg, 1 left side of head), confusion and memory issues, reactivation of allergies previously under control, diabetes going out of control, weight gain, deconditioning leading to worsening of previously existing knee injury, eczema, vertigo, difficulty staying awake, swelling and redness at injection site lasting 16 days. Second phase: after recovery from flu-like illness, tests (see below) indicate continuing problems developed after vax (newly diagnosed with Hashimoto's Disease) and worsening of some existing problems (heart, diabetes, weight), newly diagnosed with neuro problem with Word Finding, continued difficulty staying awake (as of November 2021.)
Fatigue beginning about four hours after shot continuing for 72 hours, body aches same, chills, armpit and upper left pectoral pain.
Pediatric vaccine given to 19-year-old; MD informed; once outside vaccine records were reconciled and patient was shown to already have two dose of HAV vaccine, so, per MD, no re-vaccination needed
8 or 9 inch pain which ran down her abdomen about 1 inch under her left breast; No Appetite; No Energy; fever of 103.9; Tired; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (8 or 9 inch pain which ran down her abdomen about 1 inch under her left breast), DECREASED APPETITE (No Appetite), ASTHENIA (No Energy), PYREXIA (fever of 103.9) and FATIGUE (Tired) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced ABDOMINAL PAIN (8 or 9 inch pain which ran down her abdomen about 1 inch under her left breast), DECREASED APPETITE (No Appetite), ASTHENIA (No Energy), PYREXIA (fever of 103.9) and FATIGUE (Tired). The patient was treated with PARACETAMOL (TYLENOL) 09-Jan-2021 for Fever, at an unspecified dose and frequency and TROLAMINE SALICYLATE (ASPERCREME [TROLAMINE SALICYLATE]) 09-Jan-2021 for Abdominal pain, at an unspecified dose and frequency. On 09-Jan-2021, ABDOMINAL PAIN (8 or 9 inch pain which ran down her abdomen about 1 inch under her left breast), DECREASED APPETITE (No Appetite), ASTHENIA (No Energy), PYREXIA (fever of 103.9) and FATIGUE (Tired) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Jan-2021, Body temperature: 103.9 (High) Fever 103.9 was reported.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
In mid-January 2021, after receiving my first dose of the Moderna Covid vaccine on January 11, I began to see hair loss from the scalp, as noted by hair on my hands in the shower.  The shedding became very accelerated in February 2021 after receiving my second dose of the the Covid vaccine on February 8, 2021.    Between February and March 2021, I consulted with two dermatologists and a rheumatologist, who ordered a number of blood tests, which ruled out vitamin deficiencies, anemia, systemic auto-immune disease, thyroid problems, liver problems, hormonal disregulation, syphilis, and other conditions which could explain the sudden and rapid hair loss. By April 2021, the hair on my scalp had been reduced to less than 30%, and shedding was also evident from chest, arms, legs, underarms and pubic areas.  On April 13, 2021, I saw Dr.   (my third dermatologist), and she diagnosed me with Alopeca Areata, and ordered a biopsy of the scalp which confirmed the diagnosis.  Dr.  has explained that the Alopecia Areata was most likely brought about because my immune system was highly activated after receiving the COVID vaccine.    Dr.  initially prescribed me with a tapering 25-day regimen of oral prednisone, starting with 80 mg for 5 days, then 60 mg, 40 mg, 20 mg, and 10 mg; each for 5 days.  However, when I during the stage of taking 20 mg, I shared that I was still observing some shedding, and so she instructed me to stay on 20 mg for the remainder of the 25 days.  On May 11, 2021 I saw Dr.  for follow up.  She said she was seeing some progress.  I had shaved my scalp by that point, so I was not seeing any more shedding.  She gave me an intra-muscular injection of Prednisone (80 mg) and steroid scalp injections, and she prescribed for me to stay on 20 mg/daily of oral Prednisone for the 30 day period until our next follow up appointment.  On June 14, 2021 I saw Dr.  for follow up.  By that time I had begin to see some regrowth on scalp.  She gave me the steroid scalp injections, and prescribed me to taper off the Prednisone over 10 days (5 days at 10 mg and 5 days at 5 mg).  She also prescribed a compounded scalp topical ointment which contains Retinoic Acid 0.025%/Minoxidil 8%/Triamcinolone 0.1%   As of this writing I am using the ointment almost daily and continue to see slow regrowth through out my scalp.
The day after, I felt bad in the evening, I could not figure what was it. I felt achy, my back hurts, on the weekend I went to the doctor on Monday (because the holydays could not go before). Sunday night I felt pain and the doctor said it was a real bad urinary infection. They gave me antibiotics, I took them for 5-7 days, then I was fine.
Patient had Hep A, Varicella, and Menactra on Monday, 4/14/08. On Tuesday evening onset of red blotchy rash on face. Flared up post using Proactiv solution and the mask. Has used product 3x a week for one year. Rash was raised irregular shaped bumps on face mild spoke with me, the nurse and thought he was more likely related to the Proactiv. On Friday, 4/18 mother phoned to inform that still has a rash but mild. also noted that at site of shots on left arm...the Menactra and Hep A  swollen about size of quarter. Swelling went away in 48 hours.
second dose yesterday 20Dec2021/1st dose on 14Oct2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose yesterday 20Dec2021/1st dose on 14Oct2021) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Dec-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Dec-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose yesterday 20Dec2021/1st dose on 14Oct2021). On 20-Dec-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose yesterday 20Dec2021/1st dose on 14Oct2021) had resolved.            Concomitant products was not provided. Treatment medication was not reported.   This case was linked to MOD-2021-406165 (Patient Link).